metastatic solid tumors

Lilly’s Retevmo receives FDA approval to treat solid tumours
Pharmaceutical Business Review
Thu, 09/22/22 - 10:13 am
Eli Lilly
FDA
Retevmo
solid tumors
metastatic solid tumors
FDA starts speedy review of Loxo’s site-agnostic cancer drug larotrectinib
Fierce Biotech
Tue, 05/29/18 - 11:41 am
FDA
Loxo Oncology
Bayer
metastatic solid tumors
larotrectinib